These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32339440)

  • 1. Improved glucose tolerance with DPPIV inhibition requires β-cell SENP1 amplification of glucose-stimulated insulin secretion.
    Ferdaoussi M; Smith N; Lin H; Bautista A; Spigelman AF; Lyon J; Dai X; Manning Fox JE; MacDonald PE
    Physiol Rep; 2020 Apr; 8(8):e14420. PubMed ID: 32339440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet-Fed Mice.
    Lin H; Smith N; Spigelman AF; Suzuki K; Ferdaoussi M; Alghamdi TA; Lewandowski SL; Jin Y; Bautista A; Wang YW; Manning Fox JE; Merrins MJ; Buteau J; MacDonald PE
    Diabetes; 2021 Nov; 70(11):2626-2638. PubMed ID: 34462260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.
    Ferdaoussi M; Dai X; Jensen MV; Wang R; Peterson BS; Huang C; Ilkayeva O; Smith N; Miller N; Hajmrle C; Spigelman AF; Wright RC; Plummer G; Suzuki K; Mackay JP; van de Bunt M; Gloyn AL; Ryan TE; Norquay LD; Brosnan MJ; Trimmer JK; Rolph TP; Kibbey RG; Manning Fox JE; Colmers WF; Shirihai OS; Neufer PD; Yeh ET; Newgard CB; MacDonald PE
    J Clin Invest; 2015 Oct; 125(10):3847-60. PubMed ID: 26389676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans.
    Dai XQ; Plummer G; Casimir M; Kang Y; Hajmrle C; Gaisano HY; Manning Fox JE; MacDonald PE
    Diabetes; 2011 Mar; 60(3):838-47. PubMed ID: 21266332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
    Reimer MK; Holst JJ; Ahrén B
    Eur J Endocrinol; 2002 May; 146(5):717-27. PubMed ID: 11980629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
    Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
    Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function.
    Morita A; Mukai E; Hiratsuka A; Takatani T; Iwanaga T; Lee EY; Miki T
    Endocrine; 2016 Mar; 51(3):429-39. PubMed ID: 26349938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
    Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
    Bhattacharjee A; Allister EM; Wheeler MB
    Can J Physiol Pharmacol; 2012 May; 90(5):663-8. PubMed ID: 22530993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological stimulation of serotonin 5-HT1B receptors enhances increases in plasma active glucagon-like peptide-1 levels induced by dipeptidyl peptidase-4 inhibition independently of feeding in mice.
    Nonogaki K; Kaji T
    Diabetes Metab; 2015 Nov; 41(5):425-8. PubMed ID: 26234524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
    Kelly A; Sheikh S; Stefanovski D; Peleckis AJ; Nyirjesy SC; Eiel JN; Sidhaye A; Localio R; Gallop R; De Leon DD; Hadjiliadis D; Rubenstein RC; Rickels MR
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2617-2634. PubMed ID: 34406395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization.
    Shah P; Ardestani A; Dharmadhikari G; Laue S; Schumann DM; Kerr-Conte J; Pattou F; Klein T; Maedler K
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1163-72. PubMed ID: 23633194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin inhibition in mouse islets enhances insulin secretion in a GLP-1 receptor dependent manner.
    Esser N; Barrow BM; Choung E; Shen NJ; Zraika S
    Islets; 2018; 10(5):175-180. PubMed ID: 30142012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet.
    Nakaya K; Kubota N; Takamoto I; Kubota T; Katsuyama H; Sato H; Tokuyama K; Hashimoto S; Goto M; Jomori T; Ueki K; Kadowaki T
    Metabolism; 2013 Jul; 62(7):939-51. PubMed ID: 23790528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
    Ahrén B; Sörhede Winzell M; Burkey B; Hughes TE
    Eur J Pharmacol; 2005 Oct; 521(1-3):164-8. PubMed ID: 16171801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance.
    Augstein P; Berg S; Heinke P; Altmann S; Salzsieder E; Demuth HU; Freyse EJ
    Diabetes Obes Metab; 2008 Sep; 10(10):850-61. PubMed ID: 17970756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute D-Serine Co-Agonism of β-Cell NMDA Receptors Potentiates Glucose-Stimulated Insulin Secretion and Excitatory β-Cell Membrane Activity.
    Lockridge A; Gustafson E; Wong A; Miller RF; Alejandro EU
    Cells; 2021 Jan; 10(1):. PubMed ID: 33430405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.